📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Peptide Super-Agonist Enhances T-Cell Responses to Melanoma. (2019)

First Author: Galloway SAE

Attributed to: Comprehensive analysis of T-cell receptor degeneracy and T-cell crossreactivity funded by BBSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.3389/fimmu.2019.00319

PubMed Identifier: 30930889

Publication URI: http://europepmc.org/abstract/MED/30930889

Type: Journal Article/Review

Volume: 10

Parent Publication: Frontiers in immunology

ISSN: 1664-3224